Please Wait
Applying Filters...
menu
    • menu
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Lee Pharma Ltd: Global supplier of certified APIs and formulations, driven by innovation and regulatory excellence.

    Virtual Booth

    Contact Supplier

    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    Ethypharm is an international Pharma company with European roots manufacturing and commercializing essential drugs all over the world.

    Virtual Booth

    Contact Supplier

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    Menu

    Istaroxime

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Windtree’s Istaroxime Picked for Heart Failure Presentation
    Windtree’s Istaroxime Picked for Heart Failure Presentation

    11 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/11/3130951/0/en/Windtree-Announces-Istaroxime-has-been-Chosen-for-a-Plenary-Session-Presentation-at-the-Heart-Failure-Society-of-America-2025.html

    GLOBENEWSWIRE
    11 Aug 2025
    Share Share
    Windtree's Istaroxime Phase 2 Interim Analysis Reveals Data
    Windtree's Istaroxime Phase 2 Interim Analysis Reveals Data

    05 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/05/3127444/0/en/Windtree-Announces-Istaroxime-Phase-2-Interim-Analysis-in-SCAI-Stage-C-Cardiogenic-Shock-Patients.html

    GLOBENEWSWIRE
    05 Aug 2025
    Share Share
    Windtree Receives US Patent for Istaroxime in Acute Heart Failure
    Windtree Receives US Patent for Istaroxime in Acute Heart Failure

    02 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/02/3109196/0/en/Windtree-Announces-Issuance-of-Istaroxime-Patent-for-the-United-States-for-Acute-Heart-Failure.html

    GLOBENEWSWIRE
    02 Jul 2025
    Share Share
    Windtree's Istaroxime Phase 2 Study Hits Enrollment Target
    Windtree's Istaroxime Phase 2 Study Hits Enrollment Target

    30 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/30/3107549/0/en/Windtree-Announces-Istaroxime-Phase-2-Cardiogenic-Shock-Study-Hits-Enrollment-Target-for-Planned-Interim-Analysis.html

    GLOBENEWSWIRE
    30 Jun 2025
    Share Share
    Windtree Therapeutics to Release Istaroxime Study Interim Results
    Windtree Therapeutics to Release Istaroxime Study Interim Results

    22 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/22/3086575/0/en/Windtree-Therapeutics-Announces-Istaroxime-Cardiogenic-Shock-SCAI-Stage-C-Phase-2-Study-Planned-Interim-Analysis-Results-Targeted-for-July-2025.html

    GLOBENEWSWIRE
    22 May 2025
    Share Share
    Windtree Shares Istaroxime Data at ESC Heart Failure Conference
    Windtree Shares Istaroxime Data at ESC Heart Failure Conference

    19 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/19/3083943/0/en/Windtree-Therapeutics-Announces-Istaroxime-Presentation-at-European-Society-of-Cardiology-Heart-Failure-Conference.html

    GLOBENEWSWIRE
    19 May 2025
    Share Share